These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6638413)

  • 1. Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment.
    Thurnheer U; Müller U; Stoller R; Lanner A; Hoigné R
    Allergy; 1983 Oct; 38(7):465-75. PubMed ID: 6638413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a 12-week maintenance interval in patients treated with Hymenoptera venom immunotherapy.
    Kochuyt AM; Stevens EA
    Clin Exp Allergy; 1994 Jan; 24(1):35-41. PubMed ID: 8156444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology.
    Bousquet J; Müller UR; Dreborg S; Jarisch R; Malling HJ; Mosbech H; Urbanek R; Youlten L
    Allergy; 1987 Aug; 42(6):401-13. PubMed ID: 3310714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Desensitization of allergy to hymenoptera venoms].
    Przybilla B; Ruëff F
    Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of allergy to hymenoptera venoms.
    Hamilton RG
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of bee venom immunotherapy in children and adolescents.
    Urbanek R; Forster J; Kuhn W; Ziupa J
    J Pediatr; 1985 Sep; 107(3):367-71. PubMed ID: 4032132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect allergy. Predictive value of diagnostic tests: a three-year follow-up study.
    Mosbech H; Christensen J; Dirksen A; Søborg M
    Clin Allergy; 1986 Sep; 16(5):433-40. PubMed ID: 3779939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bee venom immunotherapy: clinical and immunologic observations.
    Bar-Sela S; Levo Y
    Ann Allergy; 1981 Dec; 47(6):460-3. PubMed ID: 7325420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insect allergy. A comparative study including case histories and immunological parameters.
    Mosbech H
    Allergy; 1984 Oct; 39(7):543-9. PubMed ID: 6496884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rush Venom Immunotherapy in Children.
    Confino-Cohen R; Rosman Y; Goldberg A
    J Allergy Clin Immunol Pract; 2017; 5(3):799-803. PubMed ID: 27914814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years.
    Wyss M; Scheitlin T; Stadler BM; Wüthrich B
    Allergy; 1993 Feb; 48(2):81-6. PubMed ID: 8457037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.